BioCryst Pharmaceuticals: Q2 Earnings Insights

BioCryst Pharmaceuticals BCRX reported its Q2 earnings results on Thursday, August 4, 2022 at 07:00 AM.

Here's what investors need to know about the announcement.

Earnings

BioCryst Pharmaceuticals beat estimated earnings by 5.88%, reporting an EPS of $-0.32 versus an estimate of $-0.34.

Revenue was up $15.57 million from the same period last year.

Past Earnings Performance

Last quarter the company missed on EPS by $0.03 which was followed by a 7.06% drop in the share price the next day.

Here's a look at BioCryst Pharmaceuticals's past performance:

To track all earnings releases for BioCryst Pharmaceuticals visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.